Metabolomic Profiling to Identify Potential Serum Biomarkers for Schizophrenia and Risperidone Action

  • Jiekun Xuan
    Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, China
  • Guihua Pan
    Shanghai Institute of Mental Health, Shanghai 200030, China
  • Yunping Qiu
    Department of Nutrition, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, North Carolina 28081, United States
  • Lun Yang
    Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, China
  • Mingming Su
    David H. Murdock Research Institute, Kannapolis, North Carolina 28081, United States
  • Yumin Liu
    School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China
  • Jian Chen
    Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, China
  • Guoyin Feng
    Shanghai Institute of Mental Health, Shanghai 200030, China
  • Yiru Fang
    Shanghai Institute of Mental Health, Shanghai 200030, China
  • Wei Jia
    Department of Nutrition, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, North Carolina 28081, United States
  • Qinghe Xing
    Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, China
  • Lin He
    Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, China

書誌事項

公開日
2011-11-08
DOI
  • 10.1021/pr2006796
公開者
American Chemical Society (ACS)

この論文をさがす

収録刊行物

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ